机译:多期,公开,调查员启动的IV阶段IV临床试验,以评估伊内代牛蛋白凝胶,0·015%的疗效和头皮,0·05%的韩国患者在韩国患者中进行疗效和安全性。 角化症(完美完美)
Department of DermatologyAjou University School of MedicineSuwon Republic of Korea;
Department of DermatologyAjou University School of MedicineSuwon Republic of Korea;
Department of DermatologyAjou University School of MedicineSuwon Republic of Korea;
Department of DermatologySeoul National University College of MedicineSeoul Republic of Korea;
Department of DermatologyKorea University College of MedicineSeoul Republic of Korea;
Department of DermatologyDong‐A University College of MedicineBusan Republic of Korea;
Department of DermatologySungkyunkwan University School of MedicineSeoul Republic of Korea;
Department of DermatologyYonsei University College of MedicineSeoul Republic of Korea;
Department of DermatologyChonnam National University Medical SchoolGwangju Republic of Korea;
Department of DermatologyKorea University College of Medicine123 Jeokgeum‐ro Danwon‐gu Ansan 15355;
机译:多期,公开,调查员启动的IV阶段IV临床试验,以评估伊内代牛蛋白凝胶,0·015%的疗效和头皮,0·05%的韩国患者在韩国患者中进行疗效和安全性。 角化症(完美完美)
机译:反应“IV IV静脉头到头随机对照试验比较ingenol浆浆0·015%凝胶与双氯芬酸钠3%凝胶治疗面部或头皮上的光化角膜病(Scalp):来自作者的回复
机译:反应“IV IV IV头部到头随机对照试验比较Ingenol浆浆0·015%凝胶与双氯芬酸钠3%凝胶用于治疗面部或头皮上的光化角膜病
机译:一项由研究人员发起的研究旨在评估冷冻治疗后背甲肥厚性光化性角化病的冷冻手术后使用0.05%丁香酚丁二醇酯的安全性和有效性
机译:Ingenol浆液凝胶在胸部全面,Balding头皮或大约250cm 2上的野外角膜病发生的疗效和安全性:III期,随机,受控试验